Regarding "Eteplirsen for the treatment of Duchenne muscular dystrophy".
Publication
, Journal Article
Unger, EF; Califf, RM
Published in: Ann Neurol
January 2017
Duke Scholars
Published In
Ann Neurol
DOI
EISSN
1531-8249
Publication Date
January 2017
Volume
81
Issue
1
Start / End Page
162 / 164
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- Muscular Dystrophy, Duchenne
- Morpholinos
- Humans
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Unger, E. F., & Califf, R. M. (2017). Regarding "Eteplirsen for the treatment of Duchenne muscular dystrophy". Ann Neurol, 81(1), 162–164. https://doi.org/10.1002/ana.24842
Unger, Ellis F., and Robert M. Califf. “Regarding "Eteplirsen for the treatment of Duchenne muscular dystrophy".” Ann Neurol 81, no. 1 (January 2017): 162–64. https://doi.org/10.1002/ana.24842.
Unger EF, Califf RM. Regarding "Eteplirsen for the treatment of Duchenne muscular dystrophy". Ann Neurol. 2017 Jan;81(1):162–4.
Unger, Ellis F., and Robert M. Califf. “Regarding "Eteplirsen for the treatment of Duchenne muscular dystrophy".” Ann Neurol, vol. 81, no. 1, Jan. 2017, pp. 162–64. Pubmed, doi:10.1002/ana.24842.
Unger EF, Califf RM. Regarding "Eteplirsen for the treatment of Duchenne muscular dystrophy". Ann Neurol. 2017 Jan;81(1):162–164.
Published In
Ann Neurol
DOI
EISSN
1531-8249
Publication Date
January 2017
Volume
81
Issue
1
Start / End Page
162 / 164
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- Muscular Dystrophy, Duchenne
- Morpholinos
- Humans
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences